News
-
-
-
PRESS RELEASE
GB Sciences Signs Letter of Intent for a License to Develop and Market Their Cannabinoid-Based Parkinson’s Formulation With Endopure Life Sciences
GB Sciences partners with Endopure Life Sciences for licensing deal on cannabinoid-based treatments for neurological disorders in Brazil and South America, addressing growing market demand -
-
-
-